| Roche Pharma (Schweiz) AG - Madopar 125, Kapseln | | 38096 | | 02 | | Madopar 125 | | Kapseln | | N04BA02 | | Levodopa and Decarboxylase Inhibitor | | 27.06.1973 | | |
| | Composition | | levodopum 100.0 mg, benserazidum 25.0 mg ut benserazidi hydrochloridum, cellulosum microcristallinum, talcum, povidonum K 90, magnesii stearas, Kapselhülle: E 172 (rubrum), E 171, E 132, gelatina, Drucktinte: lacca, propylenglycolum, ammoniae solutio 28 per centum, kalii hydroxidum, E 172 (nigrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Benserazide | 25 mg | | Levodopa | 100 mg |
| | BAG: Active Agent | Dose |
|---|
| Benserazide | 25 mg | | Levodopa | 100 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | Ammoniae Solutio | 28 | | | | | | | | | color. | | | | color. | | | | color. | | Gelatina | | | | | | | | | | Drucktinte | | | | | | Per Centum | | | | | 90 | | | | | | | Propylenglycol | | | | Talcum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 036 | 100 Capsule(s) | 11.01 | 28.30 | B | SL | No |
|
|
